Paul Austin, founder of Third Wave, joined us to discuss the what and why behind safely microdosing psychedelics for greater creativity, flow, and focus. What follows is a transcript from the conversation.
Paul Austin, founder of Third Wave, joined us to discuss the what and why behind safely microdosing psychedelics for greater creativity, flow, and focus. What follows is a transcript from the conversation.
Dr. Julie Holland Holland takes us on a deep dive into the science behind psychedelic compounds that modulate neuroplasticity and how plant medicines are being used to effectively heal trauma and nurture connection.
Founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), Rick Doblin shares with us the latest news on MAPS main project regarding MDMA assisted-psychotherapy for PTSD. We explore how we can utilize psychedelics in mainstream medicine to move these powerful tools into wider use.
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He shares the in depth founding story of MAPS, and gives a glimpse into what he's currently working on. Psychedelics have played a huge role in shaping cultures throughout history. Join us to learn about what we can expect for the future of psychedelic research and how the way they are perceived in our culture will continue to change.
We experience a stress response when we feel a threat, whether the threat is real or perceived. Teaching our bodies to respond appropriately to stressors is key in maintaining wellness. Dr. David Rabin joins us to discuss forward-thinking approaches to train the mind to turn on the parasympathetic nervous system and relieve chronic stress.
If neurohacking is about upgrading the hardware our consciousness runs on, we would be remiss not to mention these technologies of altered states.